Table 2 Summary of disease severity, treatment details, and outcomes
| Â | Â | All patients |
|---|---|---|
|  |  | (n = 65) |
Disease severity, n (%) | Mild | 49 (75) |
| Â | Moderate | 6 (9) |
| Â | Severe | 9 (14) |
| Â | Critical | 1 (2) |
Symptoms, n (%) | Fever | 54 (83) |
| Â | Sore throat | 35 (54) |
| Â | Cough | 28 (43) |
| Â | Nasal mucus | 11 (17) |
| Â | Headache | 11 (17) |
| Â | Dyspnea | 9 (14) |
| Â | Arthralgia | 9 (14) |
| Â | Dysgeusia | 2 (3) |
| Â | Nausea or vomiting | 2 (3) |
| Â | Diarrhea | 1 (2) |
Hospitalization, n (%) | Â | 17 (26) |
Intensive care unit admission, n (%) | Â | 1 (2) |
Antivirals, n (%) | Molnupiravir | 57 (88) |
| Â | Remdesivir | 16 (25) |
Other treatment, n (%) | Dexamethasone | 10 (15) |
| Â | Heparin | 5 (8) |
| Â | Baricitinib | 1 (2) |
| Â | Methylprednisolone | 1 (2) |
| Â | MMF withdrawal/reduction | 40 (62) |
| Â | CNI withdrawal/reduction | 19 (29) |
| Â | Oxygen therapy | 10 (15) |
| Â | Mechanical ventilation | 1 (2) |
Outcome, n (%) | Without hospitalization | 48 (74) |
| Â | Discharged | 17(26) |
| Â | Death | 0 (0) |